simulating a secure solution for the us drug supply chain

32
Simulating a Secure Solution for the US Drug Supply Chain Robert Celeste Partner at RC Partners, Former Senior Director at GS1 US

Upload: simul8-corporation

Post on 16-Jul-2015

266 views

Category:

Healthcare


0 download

TRANSCRIPT

Page 1: Simulating a Secure Solution for the US Drug Supply Chain

Simulating a Secure Solution

for the US Drug Supply

Chain

Robert Celeste

Partner at RC Partners,

Former Senior Director at GS1 US

Page 2: Simulating a Secure Solution for the US Drug Supply Chain

SIMUL8 Corporation | SIMUL8.com | [email protected]

1 800 547 6024 | +44 141 552 6888

Presenters

Robert Celeste

Partner at RC Partners,

former Senior Director at GS1 US

Page 3: Simulating a Secure Solution for the US Drug Supply Chain

SIMUL8 Corporation | SIMUL8.com | [email protected]

1 800 547 6024 | +44 141 552 6888

Page 4: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 4

Page 5: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 5

Page 6: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 6

… ARE PRODUCTS THAT NOBODY WANTS.

Page 7: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 7

Page 8: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 8

Vial height is

approximately

34 mm

Vial height is

approximately

35 mm

Amgen Counterfeit

Page 9: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 9

Page 10: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 10

Page 11: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 11

Page 12: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 12

A growing number

of countries require

a standard means

of identifying Rx

Products,

Authenticating

their entry into

commerce and

tracing them back

to their source

Page 13: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 13

Page 14: Simulating a Secure Solution for the US Drug Supply Chain

HOW COULD WE PROVE THAT IT WAS POSSIBLE TO CREATE WHAT THE LAW REQUIRED?

PARTNERS © RC Partners 2015 14

Pro

du

ct

Ce

rtific

atio

nPe

dig

ree

Da

ta

Ownership Ownership

Page 15: Simulating a Secure Solution for the US Drug Supply Chain

THE US PHARMACEUTICAL SUPPLY CHAIN – SIMPLE VIEW

Manufacturer Wholesaler PharmacyContract

ManufacturerRaw Material

SupplierWholesaler

Limited number of Distributors creates

a Pilot and Implementation

bottleneck

Multiple Scenarios, Inference Models and

Exceptions are difficult and

expensive to test in the actual supply

chain

PARTNERS © RC Partners 2015 15

Page 16: Simulating a Secure Solution for the US Drug Supply Chain

WHAT COULD ATTEMPT TO UNDERSTAND FROM THE SIMULATION?

PARTNERS © RC Partners 2015 16

Scenario Item level T&T Lot Level T&T 2nd Sn, 1 up, 1 dn

Counterfeit introduced in return

Counterfeit introduced via repackaging

Counterfeit introduced via wholesale

Cargo theft – sold to hospital

1. Can a counterfeit be detected by a legitimate trading partner?

2. Can a counterfeit be hidden by an illegitimate trading partner?

3. What is the mechanism for detection (trading partner, inspection, etc.)?

For given regulatory requirements, business rules, data set and architecture:

Page 17: Simulating a Secure Solution for the US Drug Supply Chain

WHAT IF THERE WERE MULTIPLE INTERPRETATIONS OF THE LAW?

PARTNERS © RC Partners 2015 17

Scenario Item level T&T Lot Level T&T 2nd Sn, 1 up, 1 dn

Counterfeit introduced in return

Counterfeit introduced via repackaging

Counterfeit introduced via wholesale

Cargo theft – sold to hospital

1. Can a counterfeit be detected by a legitimate trading partner?

2. Can a counterfeit be hidden by an illegitimate trading partner?

3. What is the mechanism for detection (trading partner, inspection, etc.)?

For given regulatory requirements, business rules, data set and architecture:

Change a

Rule or

process step

Re-Run the

Model

Page 18: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 18

Scenario Setup(Policy Decisions)

Page 19: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 19

Page 20: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 20

Reports and Analysis(Scenario Impact)

Page 21: Simulating a Secure Solution for the US Drug Supply Chain

THE BIG PICTURE

PARTNERS © RC Partners 2015 21

Page 22: Simulating a Secure Solution for the US Drug Supply Chain

”A WHOLESALER CAN NOT RECEIVE AN ITEM UNLESS THE PEDIGREE MATCHED”

PARTNERS © RC Partners 2015 22

Page 23: Simulating a Secure Solution for the US Drug Supply Chain

WAS THAT A MISTAKE OR CRIMINAL ACTIVITY?

PARTNERS © RC Partners 2015 23

Page 24: Simulating a Secure Solution for the US Drug Supply Chain

© RC Partners 2015

PARTNERS

Page 25: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 25

Page 26: Simulating a Secure Solution for the US Drug Supply Chain

© RC Partners 2015

PARTNERS

Page 27: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 27

Page 28: Simulating a Secure Solution for the US Drug Supply Chain

© RC Partners 2015

PARTNERS

Page 29: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 29

Page 30: Simulating a Secure Solution for the US Drug Supply Chain

PARTNERS © RC Partners 2015 30

Page 31: Simulating a Secure Solution for the US Drug Supply Chain

[email protected]

WWW.RCPARTNERS.BIZ

PARTNERS © RC Partners 2015 31

Page 32: Simulating a Secure Solution for the US Drug Supply Chain

SIMUL8 Corporation | SIMUL8.com | [email protected]

1 800 547 6024 | +44 141 552 6888

QUESTIONS

• Please forward any topics you would like

to see covered to [email protected]

• Continue the discussion on SIMUL8 in

Health – LinkedIn Group